Johnson & Johnson Innovative Medicine · 3 hours ago
Director, Global Commercial Lead, Bladder Cancer, TAR 210 (ErdaiDRS)
Raritan, NJ
Full-time
Onsite
Director/Executive
$150K/yr - $259K/yr
7+ years expJohnson & Johnson Innovative Medicine is seeking a Director, Global Commercial Lead for Bladder Cancer, TAR 210 (ErdaiDRS) located in Raritan, NJ. The role involves leading the commercial strategy, launch excellence, and market development efforts for the bladder cancer portfolio, collaborating with various teams to optimize product value and enhance customer solutions.
Pharmaceuticals
Responsibilities
Lead commercial strategy, launch excellence, market shaping & development, go-to-market model, and LCM efforts for TAR 200 +/- CET
Coordinate with business partners to ensure strategic alignment and execution
Establishing unique solutions to elevate the customer experience
Regions to develop, shape and implement commercial strategies, precision medicine/testing strategies, tactics, customer solutions and messaging
Medical Affairs to ensure robust publication plans and enduring/differentiating data generation
Market Access in development of value propositions to support/bolster reimbursement and approvals globally
Partner across a diverse matrix of collaborators to deliver results
R&D and Regulatory to bring commercial insight, develop/strengthen the Target Product Profile (TPP), and implement the broader vision for J&J’s leadership in bladder cancer
Key cross-functional partners (Analytics, Finance, Competitive Intelligence, etc.) to develop differentiating value proposition and commercial forecast valuation models
Create a culture of patient centricity and best practice sharing
Qualification
Required
A minimum of a Bachelor's degree is required
A minimum of 7 years of dynamic experience in the pharmaceutical industry is required
A minimum of 3 years demonstrated in-line marketing, market access, marketing support, or sales management/training experience implementing marketing strategy is required
An ability to handle multiple demands and priorities on time, lead teams, gain alignment and driving decision making is required
Strong executive, verbal and written communication skills are required, along with demonstrated presentation skills
Preferred
Postgraduate qualification, PhD, MBA, or other graduate degree or equivalent experience is strongly preferred
Prior Oncology experience or scientific background is strongly preferred
Senior brand responsibility, alliance management experience, people management, product launch, experience in working with global teams and a strong understanding of pharmaceutical development is preferred
Significant international experience; specifically, previous working experience with complicated geographies; working knowledge of differing reimbursement markets is preferred
Benefits
Employees are eligible to participate in the Company’s consolidated retirement plan (pension) and savings plan (401(k))
This position is eligible to participate in the Company’s long-term incentive program.
Vacation –120 hours per calendar year
Sick time - 40 hours per calendar year; for employees who reside in the State of Colorado –48 hours per calendar year; for employees who reside in the State of Washington –56 hours per calendar year
Holiday pay, including Floating Holidays –13 days per calendar year
Work, Personal and Family Time - up to 40 hours per calendar year
Parental Leave – 480 hours within one year of the birth/adoption/foster care of a child
Bereavement Leave – 240 hours for an immediate family member: 40 hours for an extended family member per calendar year
Caregiver Leave – 80 hours in a 52-week rolling period10 days
Volunteer Leave – 32 hours per calendar year
Military Spouse Time-Off – 80 hours per calendar year
Company
Johnson & Johnson Innovative Medicine
Johnson and Johnson Innovative Medicine focuses on developing medical solutions for some of the challenging diseases and medical conditions.
10001+ employees
Funding
Current Stage
Late StageLeadership Team
Molly Perkins
VP, Head of Cell & Genetic Medicines Discovery
Recent News
2025-08-14
Company data provided by crunchbase